KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic ResistanceKunihiko Hinohara, Kornélia Polyák, Hua‐Jun Wu et al.|Cancer Cell|2018Cited by 255
VIPER: Visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysisMacIntosh Cornwell, Henry W. Long, Mahesh Vangala et al.|BMC Bioinformatics|2018Cited by 234
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rachel Schiff, Rinath Jeselsohn et al.|Proceedings of the National Academy of Sciences|2016Cited by 185
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibitionAnne Fassl, Piotr Siciński, Christopher T. Brain et al.|Science Advances|2020Cited by 105
Abemaciclib plus fulvestrant vs fulvestrant alone for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy: Primary outcome of the phase 3 postMONARCH trial.Kevin Kalinsky, Seth A. Wander, Giampaolo Bianchini et al.|Journal of Clinical Oncology|2024Cited by 75